Two dedicated volunteers have reached a prestigious milestone with the American Heart Association, the world’s leading nonprofit organization devoted to a world of healthier lives for all, for their personal passion and commitment to advance women’s heart health.
Updated: Novartis axes PhIII peanut allergy trial, expects to test ‘optimized dosing’ in new trial later this year
Novartis has again culled a late-stage trial of a biologic that it once thought could succeed Xolair, its Genentech-partnered anti-inflammatory treatment for asthma and other
January 19, 2024